Hypera (FRA:HM6A) FFO


FRA:HM6A Hypera SA FRA:HM6A
92 GF Score
Price €3.54
GF Value €5.23
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Hypera FFO?

FFO (Funds from operations) only applies to REITs.

FRA:HM6A
92GF Score
Hypera SA FRA:HM6A
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Hypera (FRA:HM6A) Overvalued in 2026?

Based on GuruFocus' analysis, Hypera stock appears to be undervalued. The current stock price of €3.54 is trading 32.3% below its estimated GF Value™ of €5.23. GuruFocus considers Hypera to be Possible Value Trap.

Key valuation signals for FRA:HM6A:

  • FFO:
  • GF Value™: €5.23 vs. price of €3.54 (32.3% below fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the FRA:HM6A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hypera Business Description

Address Avenida Magalhaes de Castro, 4800, 240 Floor Continental Tower Building, Bairro Cidade Jardim, Sao Paulo, SP, BRA, CEP 05676-120
Hypera SA is a specialty and generic drug manufacturing company. The company operates in the prescription medicines, over-the-counter (OTC) medicines, branded generics, and generics, and skincare segments within the retail pharmaceutical market. The company also has a wide sales and distribution structure. The company's product portfolio includes key brands in Gastroenterology, Pain, Sun Protection, Skin Moisture, and Cleansing within the over-the-counter (OTC) and Skincare segments, as well as new products in Cardiology, Central Nervous System, and Respiratory System within the prescription medicines segment.
92GF Score

Get the complete analysis for FRA:HM6A

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.54
Price
€5.23
GF Value